CEAVLUAL Trademark

Trademark Overview


On Thursday, April 20, 2023, a trademark application was filed for CEAVLUAL with the United States Patent and Trademark Office. The USPTO has given the CEAVLUAL trademark a serial number of 97899037. The federal status of this trademark filing is FIRST EXTENSION - GRANTED as of Friday, September 20, 2024. This trademark is owned by Pfizer Inc.. The CEAVLUAL trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of autoimmune, cardiovascular, central nervous system, endocrine, gastrointestinal, genetic, infectious, inflammatory, kidney, liver, menopausal, metabolic, musculoskeletal, neurodegenerative, neurological, neuromuscular and viral diseases and disorders; pharmaceutical preparations for the treatment of blood disorders, bone growth disorders, skin disorders, arthritis, cancer, hypertension, pain, stroke, obesity and diabetes; pharmaceutical preparations, namely, anti-infective preparations, medicated dermatological preparations and smoking cessation preparations; vaccines for human use
ceavlual

General Information


Serial Number97899037
Word MarkCEAVLUAL
Filing DateThursday, April 20, 2023
Status730 - FIRST EXTENSION - GRANTED
Status DateFriday, September 20, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, February 20, 2024

Trademark Statements


Goods and ServicesPharmaceutical preparations for the treatment of autoimmune, cardiovascular, central nervous system, endocrine, gastrointestinal, genetic, infectious, inflammatory, kidney, liver, menopausal, metabolic, musculoskeletal, neurodegenerative, neurological, neuromuscular and viral diseases and disorders; pharmaceutical preparations for the treatment of blood disorders, bone growth disorders, skin disorders, arthritis, cancer, hypertension, pain, stroke, obesity and diabetes; pharmaceutical preparations, namely, anti-infective preparations, medicated dermatological preparations and smoking cessation preparations; vaccines for human use

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, April 28, 2023
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NamePfizer Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNew York, NY 100012192

Party NamePfizer Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNew York, NY 100012192

Trademark Events


Event DateEvent Description
Monday, April 24, 2023NEW APPLICATION ENTERED
Friday, April 28, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, January 17, 2024ASSIGNED TO EXAMINER
Wednesday, January 17, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, February 2, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Friday, February 2, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, February 20, 2024PUBLISHED FOR OPPOSITION
Monday, March 4, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, April 16, 2024NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Friday, September 20, 2024SOU TEAS EXTENSION RECEIVED
Friday, September 20, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, September 20, 2024SOU EXTENSION 1 FILED
Friday, September 20, 2024SOU EXTENSION 1 GRANTED